Spread the love

















Woman survived for 9 years after being given a 2-3 month prognosis and an experimental vaccine.

A common tetanus booster shot given to patients with a deadly form of brain cancer shortly before an experimental cancer vaccine prolonged their survival, a small study found. “We’ve discovered a way to enhance cancer vaccines which dramatically improves their efficacy” without significant side effects, said John Sampson, chief of neurosurgery at Duke University. Nature published the study results online Wednesday (March 11, 2015). Researchers say this could be a new way to stimulate the body’s immune system to attack tumors. The vaccine technology is in the process of being licensed to a startup company, Annias Immunotherapeutics Inc. For more information:

http://corporate.dukemedicine.org/news_and_publications/news_office/news/tetanus-shot-improves-patient-survival-with-brain-tumor-immunotherapy

Subscribe to Website: www.rawscience.tv | Facebook: https://www.facebook.com/RawScience | @RawScienceTV at https://twitter.com/rawsciencetv

Photo Credit: suitesculturelles